Xin Wei Wang

This inventor holds 22 USPTO granted patents and 3 published patent applications and 8 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The Ohio State University, Fudan University. Active years: 1999-2026.

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 59.1

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 50(Granted Patents)

Location History:

North Potomac, MD (US) (1999 - 2008)
Lilburn, GA (US) (2017 - 2020)
Liburn, GA (US) (2020)
Rockville, MD (US) (2003 - 2022)

Company Filing History:

20 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 1,575

The Ohio State University

The United States of America as Represented by the Department of Health

patents

5. 1 out of 2,202

The United States of America as Represented by the Secretary of

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12571796 - A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA (2026-03-10),

2. 11306362 - Gene signature predictive of hepatocellular carcinoma response to transcatheter arterial chemoembolization (TACE) (2022-04-19),

3. 10683558 - Selective detection of (2020-06-16),

4. 10669591 - Selective detection of (2020-06-02),

5. 9593385 - [object Object] (2017-03-14),

6. 9464324 - Methods of determining the prognosis of an adenocarcinoma (2016-10-11),

7. 9394358 - Gene signature for predicting prognosis of patients with solid tumors (2016-07-19),

8. 9125923 - Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy (2015-09-08),

9. 8735082 - Gene signature for predicting prognosis of patients with solid tumors (2014-05-27),

10. 8568977 - Compositions and methods for diagnosis and treatment of tumors (2013-10-29),

11. 8465917 - Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells (2013-06-18),

12. 8252538 - MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma (2012-08-28),

13. 8247183 - Compositions and methods for diagnosis and treatment of tumors (2012-08-21),

14. 7803380 - Compositions and methods for diagnosis and treatment of tumors (2010-09-28),

15. 7438892 - Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity (2008-10-21),

Title: The Innovative Journey of Xin Wei Wang

Introduction: Xin Wei Wang, a pioneering inventor based in Rockville, MD (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Xin Wei Wang holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Xin Wei Wang has demonstrated a remarkable ability to translate cutting-edge ideas into tangible inventions that have the potential to revolutionize industries.

Collaborations: Xin Wei Wang has collaborated with leading research institutions, universities, and companies to further his innovative pursuits, fostering a culture of creativity and excellence in the field of inventions.

Conclusion: Xin Wei Wang's relentless passion for innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventions. His impact on the technological landscape is profound and enduring.